A long medical term in plain words
What Does Growth Hormone Secretagogue Mean for CJC-1295 Ipamorelin?
This kind of drug starts a growth-hormone release. The name doesn't tell you whether the drug is safe or useful.
Why were two kinds of hormone starter made?
The first team chose the brain's route when it made CJC-1295. A natural brain hormone reaches the small gland under your brain, causing growth hormone to enter the blood. Ipamorelin's makers chose another route. Their drug acts like part of the hunger hormone. Both drugs therefore make your own gland send out growth hormone.
Doctors call any drug that starts such a release a growth hormone secretagogue. The drug isn't growth hormone placed in your body. Your gland still makes the hormone and sends it out in rises. The long drug keeps the brain route active longer, while ipamorelin starts a shorter rise through the hunger route.
Separate studies found that growth hormone went up after each drug. CJC-1295 also raised growth factor 1, which the liver sends out to aid cell growth. The long name tells you only how a drug works. It can't show that the pair is safe, approved, or helpful. No fair human study has covered the pair.
In plain terms, both drugs make your own gland send out growth hormone.
How does a growth hormone secretagogue reach the gland?
Secretagogue is a medical word for something that makes a gland let out a substance. In this case, the substance is growth hormone. Two routes in your body matter for the pair.
The first begins with a brain hormone. CJC-1295 acts like that hormone and remains at work longer. The other begins with ghrelin, the hormone that tells you when food is needed. Ipamorelin acts like part of ghrelin. Its makers hoped to avoid some effects seen with older drugs.
Each drug fits a different protein on the gland cells. Think of the proteins as two doorbells, either of which can start a growth-hormone release. In a dish, cells exposed to both kinds reacted more than cells given one kind [5]. A small study in men also found a larger rise with related drugs [3].
These results explain the pairing idea, but they don't prove you would benefit.
What did the separate studies actually find?
The main human study was small and tested only long-lasting CJC-1295. After an injection under the skin, average growth hormone became as much as ten times, and at least twice, its first reading. The higher result remained through day six or later. Growth factor 1, a liver hormone that spurs cell growth, reached one and a half to three times its start. The rise continued for nine to eleven days. More shots left growth factor 1 high on day 28 [1].
A second study found that the body's usual rises continued, while the low point between them became higher. Average growth hormone rose 46%, and growth factor 1 rose 45% [7].
Animal work found more growth hormone after ipamorelin. Cortisol, a stress hormone, held steady even at much higher amounts [2]. The brain message controlling cortisol did the same. A 2026 review joined five fair tesamorelin studies. That drug isn't this pair. Fat deep in the belly fell, and liver fat did too. The people gained weight that wasn't fat. Growth factor 1 rose too. No serious harms were seen [8].
For your choice, keep the last result with tesamorelin rather than this pair.
Which safety answers are still missing?
One wide review gathered short studies of drugs that release growth hormone. During those brief studies, most people had no serious problem recorded. That can't answer what long use might do. The review chiefly worried about higher blood sugar because these drugs can weaken insulin [6]. Insulin carries sugar from your blood into your cells.
Cancer is another open question. Growth factor 1 helps cells grow and stay alive. Keeping growth factor 1 high might speed a cancer already present. Researchers haven't proved that this pair causes cancer. Long studies haven't tracked the effect of growth factor 1 on cancers or deaths.
The leading sports drug authority bans both drugs under its hormone rule, and neither drug is approved medicine. Sellers may label CJC-1295 Ipamorelin as a growth hormone secretagogue for research. Such a label doesn't mean people took the mixed product in a study.
Hormone readings may rise, but the result of long use is still unknown.